Phase I dose escalation study of SR271425 administered as 24-hour intravenous continuous infusion in patients with refractory solid tumors

被引：0

作者：

de Braud, F

Sessa, C

Gallerani, E

Curigliano, G

Cipolla, C

Columbo, A

Gallino, A

Schackleton, G

Zilocchi, C

Chadjaa, M

机构：

[1] Inst Europeo Oncol, Milan, Italy

[2] Oncol Inst So Bellinzona, Bellinzona, Switzerland

[3] Sanofi Aventis, Alnwick, England

[4] Sanofi Aventis, Chilly Mazarin, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：220S / 220S

页数：1